Form 8-K - Current report:
SEC Accession No. 0001493152-23-004172
Filing Date
2023-02-10
Accepted
2023-02-09 20:24:54
Documents
14
Period of Report
2023-02-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 50742
2 ex2-1.htm EX-2.1 83428
  Complete submission text file 0001493152-23-004172.txt   366096

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE lfmd-20230204.xsd EX-101.SCH 4009
4 XBRL DEFINITION FILE lfmd-20230204_def.xml EX-101.DEF 26677
5 XBRL LABEL FILE lfmd-20230204_lab.xml EX-101.LAB 36819
6 XBRL PRESENTATION FILE lfmd-20230204_pre.xml EX-101.PRE 25301
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5576
Mailing Address 236 FIFTH AVENUE SUITE 400 NEW YORK NY 10001
Business Address 236 FIFTH AVENUE SUITE 400 NEW YORK NY 10001 (866) 351-5907
LifeMD, Inc. (Filer) CIK: 0000948320 (see all company filings)

EIN.: 760238453 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39785 | Film No.: 23608103
SIC: 8011 Services-Offices & Clinics of Doctors of Medicine